Nov 5 (Reuters) - Specialty pharmaceutical company A.P. Pharma Inc posted a bigger quarterly loss on higher expenses, and said it cut 35 percent jobs and would keep several early-stage development programs on hold, to save cost and focus on its main drug candidate.
